GSP SUPPLY OF TRETINOIN 10 MG MEDICATION
About This Opportunity
TranslatedThis tender concerns the supply of Tretinoin 10 mg medication, as indicated by the title 'GSP SUMINISTRO DE MEDICAMENTO TRETINOINA 10 MG'. The specific details regarding the tendering entity (GSP), the exact quantity required, delivery timelines, and the scope of the contract are not fully elaborated in the provided description. However, it is clear that the procurement focuses on a specific pharmaceutical product, Tretinoin, at a dosage of 10 mg. This suggests a need within a healthcare sector, potentially for a government health program, a hospital, or a related medical institution. Tretinoin is a retinoid, commonly used in dermatology for treating conditions such as acne, psoriasis, and certain types of cancer. The tender likely seeks to establish a supply agreement with a qualified pharmaceutical manufacturer or distributor capable of meeting the specified quality standards and regulatory requirements for such medications. Potential bidders would need to demonstrate their capacity to provide this specific drug, adhere to stringent pharmaceutical supply chain protocols, and potentially offer competitive pricing. Further information regarding the tender process, including submission deadlines, eligibility criteria, and technical specifications, would be available in the full tender documentation. This procurement is crucial for ensuring the availability of essential medication for patient treatment.
This is a supplies contract in the health and medical services and general supplies sectors, with a focus on Pharmaceuticals and General Supplies. Located in Chile, Latin America, this opportunity is open to firms and consortiums.
Published through Chile Mercado Publico, a national government procurement portal. Public procurement tenders follow the country's national bidding regulations and may have specific eligibility and documentation requirements for the supply of goods in the health and medical services sector. Supply contracts typically require bidders to demonstrate product compliance with technical specifications, delivery capacity, and relevant certifications. This contract has already been awarded. The information is published for transparency and market intelligence purposes.
Description
Original language: SpanishThis tender, originating from Chile and accessible via the chile_mercadopublico platform, seeks the supply of Tretinoin 10 mg medication. The procurement aims to secure a reliable source of this pharmaceutical product for an unspecified contracting authority within Chile. Tretinoin is a retinoid, a derivative of Vitamin A, commonly used in dermatological treatments for conditions such as acne, photoaging, and certain types of skin cancer.
Prospective suppliers are expected to demonstrate their capability to consistently provide high-quality Tretinoin 10 mg in compliance with all relevant national and international pharmaceutical manufacturing and distribution standards. Typical requirements for such a tender would include detailed product specifications, including active pharmaceutical ingredient (API) concentration, formulation, packaging, and expiry dates. Bidders will likely need to provide evidence of regulatory approvals, such as Good Manufacturing Practices (GMP) certification, and potentially specific registrations with Chilean health authorities. Furthermore, the tender may stipulate delivery timelines, logistical arrangements, and quality control procedures. The contracting authority will be evaluating offers based on a combination of technical merit, price, and the supplier's capacity to meet the ongoing demand for this essential medication. Interested parties are encouraged to review the full tender documentation on the chile_mercadopublico portal for precise details regarding submission requirements and evaluation criteria.
Data provenance
This notice is sourced from Chile Mercado Publico and was originally published on March 7, 2026. Last refreshed 32 days ago. Original language: Spanish. BidsFactory mirrors official procurement notices and links back to the source for full legal text.
Frequently asked questions about this tender
How much was the contract awarded for?
INVERSIONES PHARMAVISAN SOCIEDAD ANONIMA was awarded the contract for CLP 47,200,000. The figure reflects the value disclosed by the contracting authority in the award notice.
Where will the contract be performed?
The contract is for delivery in Chile. Foreign bidders should review local registration, taxation, and any in-country presence requirements before submitting.
How can I submit a bid?
Visit Chile Mercado Publico to access the full notice, required documents, and submission instructions provided by the contracting authority.
Is this tender still open?
No — the contract has already been awarded to INVERSIONES PHARMAVISAN SOCIEDAD ANONIMA. The award notice is archived on BidsFactory for transparency and market intelligence.
What type of contract is this?
This is a Supplies contract in the Health & Medical sector. The classification helps bidders match the opportunity to their qualifications and registered scope of supply.
Find tenders like this automatically
Set up alerts and filters that match your business — never miss a relevant opportunity again.